ADLAI NORTYE
Adlai Nortye is a global clinical-stage biopharmaceutical company focused on innovative oncology drugs, with its R&D and global clinical operation centers in both China and the United States. With a strategic emphasis on oncology, it has built a global pipeline through collaborations and internal discoveries with more than 10 drug candidates in development.
ADLAI NORTYE
Industry:
Biotechnology Health Care Oncology Pharmaceutical
Founded:
2016-01-01
Address:
Hangzhou, Zhejiang, China
Country:
China
Website Url:
http://www.en.adlainortye.com
Total Employee:
51+
Status:
Active
Contact:
+86 571 2891 8366
Total Funding:
293 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Google Maps SSL By Default Mobile Non Scaleable Content IPv6 Nginx Microsoft Exchange Online
Similar Organizations
Alphamab Oncology
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.
Aston Sci
Aston Sci is a clinical-stage biopharmaceutical company that develops medicines in oncology, immunology, and geriatrics.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
BiolineRx
BioLineRx is a clinical-stage, publicly-traded (NASDAQ/ TASE: BLRX) biopharmaceutical development company based in Jerusalem, Israel.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
CStone Pharmaceuticals
CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.
Gankill Pharmaceutical
Gankill Pharma Co., Ltd. is conducting research on cancer treatment drugs using PSMD10.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Current Advisors List
Advisor
Current Employees Featured
Nanhai He Global Head of Drug Discovery @ Adlai Nortye
Global Head of Drug Discovery
Carsten Lu Founder, President and CEO @ Adlai Nortye
Founder, President and CEO
Lars Birgerson CMO of Adlai Nortye Ltd. & CEO of Adlai Nortye USA. @ Adlai Nortye
CMO of Adlai Nortye Ltd. & CEO of Adlai Nortye USA.
Shifeng Liu Vice President @ Adlai Nortye
Vice President
Wei Zhang CFO @ Adlai Nortye
CFO
Founder
Stock Details
Investors List
Ruihe Capital
Ruihe Capital investment in Post-IPO Equity - Adlai Nortye
Nippon Kayaku
Nippon Kayaku investment in Post-IPO Equity - Adlai Nortye
Legend Star
Legend Star investment in Series D - Adlai Nortye
Tiange Interactive Holdings
Tiange Interactive Holdings investment in Series D - Adlai Nortye
Guolian Securities
Guolian Securities investment in Series D - Adlai Nortye
TriWise Capital
TriWise Capital investment in Series D - Adlai Nortye
SDIC Fund Management
SDIC Fund Management investment in Series D - Adlai Nortye
WuXi Healthcare Ventures
WuXi Healthcare Ventures investment in Series D - Adlai Nortye
Tigermed
Tigermed investment in Series D - Adlai Nortye
ICBC Asset Management
ICBC Asset Management investment in Series C - Adlai Nortye
Official Site Inspections
http://www.en.adlainortye.com
Unable to get host informations!!!
More informations about "Adlai Nortye"
Adlai Nortye - Crunchbase Company Profile & Funding
Contact Email info@adlainortye.com; Phone Number +86 571 2891 8366; Adlai Nortye is a global clinical-stage biopharmaceutical company focused on …See details»
Adlai Nortye
Adlai Nortye is a global clinical-stage biopharmaceutical company that is developing differentiated, innovative immuno-oncology medicines. Adlai Nortye focuses on discovering and developing …See details»
Adlai Nortye Biopharma Co., Ltd. Management Team | Org Chart
Adlai Nortye Biopharma Co., Ltd. employs 46 employees. The Adlai Nortye Biopharma Co., Ltd. management team includes Audrey Xue (Associate Director Human Resources), Victoria …See details»
Adlai Nortye Biopharma Co., Ltd. - SignalHire
Adlai Nortye Biopharma Co., Ltd. is a private company that has been in the industry for 20 years. The company currently specializes in the Biotechnology, Pharmaceuticals areas. The position …See details»
Adlai Nortye - Overview, News & Similar companies - ZoomInfo
Adlai Nortye contact info: Phone number: (848) 230-7430 Website: www.adlainortye.com What does Adlai Nortye do? Founded in 2004, headquartered out of the Cayman Islands, Adlai …See details»
Adlai Nortye - Craft
Adlai Nortye has 5 employees across 2 locations and $253 m in total funding,. See insights on Adlai Nortye including office locations, competitors, revenue, financials, executives, …See details»
Adlai Nortye Company Overview, Contact Details & Competitors
First.Last@adlainortye.com: John.Doe@adlainortye.com: 96%. FirstMiddleLa@adlainortye.com: JohnMichaelDo@adlainortye.com: 1%. F_Last@adlainortye.com: ... Adlai Nortye 's main …See details»
Adlai Nortye Biopharma Co., Ltd. - cnverify.com
Sep 14, 2004 Country:China, Founding date:2004-09-14, Legal representative: Lu Yang, Registered capital:200000000RMB, Industry: Medical Research and Experimental DevelopmentSee details»
Adlai Nortye Company Profile 2024: Stock Performance …
Adlai Nortye General Information Description. Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types.See details»
i. ii. iii. iv. - ir.adlainortye.com
Financial personnel resources, including the budget, organization and quality of personnel within the Company’s finance function. v. Periodically review and discuss with the principal internal …See details»
Adlai Nortye Biopharma - VentureRadar
"Adlai Nortye is a global clinical-stage biopharmaceutical company with several innovative late-stage immuno-oncology medicines in its pipeline.See details»
Hangzhou Adlai Nortye Biopharma Co. Ltd. - synapse.zhihuiya.com
了解Hangzhou Adlai Nortye Biopharma Co. Ltd. (杭州阿诺生物医药科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的12项临床试验, 10篇新闻和1篇文献，疾病领域:肿瘤，神经 …See details»
Multiple potential first and best -in-class preclinical assets with ...
Copy or electronic distribution format)the contents of this presentation, and (ii) the confidential password assigned to you or your organization has not been, and will not be, disclosed to any …See details»
新闻资讯 - Adlai Nortye
北京时间2024年3月29日——阿诺医药集团有限公司（以下简称“阿诺医药”），一家专注于肿瘤治疗领域的创新型全球生物制药公司宣布，任命医学领域专家谢毅钊博士为研发负责人（Head …See details»
新闻资讯 - Adlai Nortye
May 23, 2024 阿诺医药致力于成为打造“全球新”肿瘤药物的创新型研发企业，为中国乃至全球患者带来更有效的治疗方案，实现将癌症变成一种慢性疾病乃至可治愈疾病的使命。欲了解更 …See details»
Yonglin Chen Email & Phone Number | Adlai Nortye USA Inc.
Get Yonglin Chen's email address (y*****@adlainortye.com) and phone number at RocketReach. Get 5 free searches.See details»
Adlainortye Security Rating - SecurityScorecard
View Adlainortye's cyber security risk rating against other vendors' scores. Explore cyber risks, data breaches, and cybersecurity incidents involving Adlainortye. ... Headquarters Hangzhou, …See details»
阿诺医药，美国上市获「备案通知书」，中信里昂、建达资本联席 …
Aug 8, 2023 阿诺医药，美国上市获「备案通知书」，中信里昂、建达资本联席承销 作者：港澳ipo上市See details»
AN0025, a novel antagonist of PGE2-receptor E-type 4 (EP4), in ...
Immune evasion is a hallmark of cancer (Hanahan, 2011 [4]. Disease progression of colorectal cancer appears influenced by the immune system and inflammatory mechanisms [5,6], ThereSee details»
Org Chart Canadian National Railway - The Official Board
Sep 21, 2024 www.cn.ca. has 48 executives +1 866 896 6601; Add an executive. Canadian National Railway (CNI) News . Anything missing? We search for you. ... Unfortunately, you …See details»